@AnotherBio Curious whether this worked. On IBKR one cannot open positions anymore but it seems to still trade. Are you still in and what are your expectations?
@Lord_of_Biotech After some more reading, I think itβs disingenuously framed. They cannot discuss financing with some investors and partnership with others. Nothing prevents them from preparing a capital raise in case the partnership does not happen.
@Lord_of_Biotech Have you ever heard of a prohibition to discuss financing and partnering at the same time? I unsuccessfully tried to find it in the AMF rulebook but are probably looking in the wrong place.
@AppleHelix Well, BMS might have taken the right decision, who knows. Thatβs part of what makes business and politics so exciting: the counter factual doesnβt exist.
It could be that both BMS and MRK chose wisely.
Do you know why it wasnβt an option for BMS to simply start both trials?
@CuiBonoCapital@RNAiAnalyst Well, Dirk referenced a tweet that said: βFDA should be about safety, the physicians and ultimately the markets decide what's efficient.β, which is a stupid statement.
I just donβt like witch hunts, thatβs all.